EyeQue announced that they have closed a Series C round and have raised more than $57 million in capital since the company was founded in 2015. EyeQue aims to bring affordable vision correction with their smartphone vision tests. The company has developed a suite of at-home vision tests using optical smartphone attachments that consumers can use to self-administer a refractive …
Sydnexis Secures $45 Million Series B Financing
Sydnexis, Inc. today announced the completion of a $45 million Series B financing led by Visionary Ventures, Blue Stem Capital, and SC Master Fund, with participation from existing investors RA Capital Management, Longitude Capital, and Medicxi. The financing will be used to fund Sydnexis’ lead candidate, SYD-101, through completion of the fully enrolled pivotal Phase 3 STAAR study for the …
Eyevensys Raises $12M in a Series B Plus Funding Round
Eyevensys announced it has raised $12 million in a Series B Plus funding round. Korea Investment Partners is leading the Series B Plus financing and existing investors will also join the round.
Global Ophthalmic Deals Total $1.2 Billion in Q2-2021
Market Scope identified 21 ophthalmic transactions totaling nearly $1.2 billion during Q2-2021. This compares with $2.3 billion from 32 transactions in Q1-2021 and $2.3 billion from 28 transactions in Q2-2020. Funds raised included investments for the development of new products and technologies, commercialization of new products, or outright purchases of products or technologies. Transactions have ranged from $250 thousand to …
Eyenuk Raises $6.2 Million to Boost its EyeArt AI System to Screen for DR
Eyenuk, of Los Angeles, announced July 20 that it had completed a financing round of $6.2 million led by investment management company AXA IM, through AXA IM Alts, with existing investors also participating.
